首页> 美国卫生研究院文献>World Journal of Gastroenterology >Mismatch repair genes (hMLH1 hPMS1 hPMS2 GTBP/hMSH6 hMSH2) in the pathogenesis of hepatocellular carcinoma
【2h】

Mismatch repair genes (hMLH1 hPMS1 hPMS2 GTBP/hMSH6 hMSH2) in the pathogenesis of hepatocellular carcinoma

机译:肝细胞癌发病机理中的错配修复基因(hMLH1hPMS1hPMS2GTBP / hMSH6hMSH2)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: DNA mismatch repair (MMR) is an important mechanism for maintaining fidelity of genomic DNA. Abnormalities in one or more MMR genes are implicated in the development of many cancers. We investigated the role of expression of MMR genes (hMLH1, hPMS1, hPMS2, GTBP/hMSH6, hMSH2) in hepatocellular carcinogenesis.METHODS: We evaluated the expression level of MMR genes in 33 hepatocellular carcinoma (HCC) cases using the multiplex reverse transcription (RT) PCR assays, as well as in 16 cases of normal adjacent hepatic tissues. β-actin gene was used as an internal control and calibrator for quantification of gene expression.RESULTS: Out of the 33 studied cases, 25 were HCV positive and 30 (90.9%) showed reduced expression in one or more of the studied MMR genes. Reduced expression was found in hMSH2 (71.9%), hMLH1 (53.3%), GTBP (51.1%), hPMS2 (33.3%) and hPMS1 (6%). A significant correlation was found between reduced expression of hPMS2 (P = 0.0069) and GTBP (P = 0.0034), hPMS2 and non-cirrhosis (P = 0.0197), hMLH1 and high grade. On the other hand, 57.1%, 50%, 20%, 18.8%, and 6% of the normal tissues distant to tumors showed reduced expression of hMSH2, hMLH1, GTBP, hPMS2, and hPMS1 respectively. Multivariate analysis revealed a significant correlation between the expression level of hMSH2 (P = 0.008), hMLH1 (P = 0.001) and GTBP (P = 0.032) and HCC, between hPMS2, GTBP and HCV-associated HCC (P<0.001, 0.002).CONCLUSION: Reduced expression of MMR genes seems to play an important role in HCV-associated HCC. hPMS2 is likely involved at an early stage of hepatocarcinogenesis since it was detected in normal adjacent tissues. Reduced expression of hPMS2 provides a growth advantage and stimulates proliferation which encourages malignant transformation in non-cirrhotic HCV-infected patients via acquisition of more genetic damages.
机译:目的:DNA错配修复(MMR)是维持基因组DNA保真度的重要机制。一个或多个MMR基因的异常与许多癌症的发生有关。我们调查了MMR基因(hMLH1,hPMS1,hPMS2,GTBP / hMSH6,hMSH2)的表达在肝细胞癌发生中的作用。方法:我们通过多重逆转录(33)评估了MMR基因在33例肝细胞癌(HCC)中的表达水平。 RT)PCR检测,以及16例正常的邻近肝组织。结果:33例病例中,HCV阳性25例,其中30例(90.9%)显示降低的一种或多种MMR基因表达。在hMSH2(71.9%),hMLH1(53.3%),GTBP(51.1%),hPMS2(33.3%)和hPMS1(6%)中发现表达降低。发现hPMS2(P = 0.0069)和GTBP(P = 0.0034),hPMS2与非肝硬化(P = 0.0197), hMLH1 和高等级表达降低之间存在显着相关性。另一方面,远离肿瘤的正常组织中,有57.1%,50%,20%,18.8%和6%的 hMSH2 hMLH1 ,< em> GTBP hPMS2 hPMS1 。多变量分析显示, hMSH2 P = 0.008), hMLH1 P = 0.001)和 GTBP P = 0.032)和HCC,介于 hPMS2 GTBP 和HCV - 相关的HCC( P <0.001,0.002)。结论:MMR基因表达的降低似乎在HCV相关的HCC中起重要作用。 hPMS2 可能与肝癌发生的早期有关,因为它是在正常的相邻组织中检测到的。 hPMS2 的减少表达提供了生长优势并刺激了增殖,从而通过获得更多的遗传损伤促进了非肝硬化HCV感染患者的恶性转化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号